N=18: Pfizer age 12-15 (Warning: Sample size small)... - Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Ado...

In participants aged 12-15 years old, BNT162b2 demonstrated 100% efficacy a Coronavirus · 7.4m followers Shared knowledge and experiences regarding COVID-19 Mitchell Tsai, Virus researcher at Harvard Medical School in 1980s Shared Mar 31 N=18: Pfizer age 12-15 (Warning: Sample size small) 100% (maybe 91-100%) efficacy (0 vaccine, 18 control in 2,260 people) Excellent news. Pfizer vaccine maybe better in ki... Read More »Loading… Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents pfizer.com 74 upvotes22 comments Mitchell Tsai, Virus researcher at Harvard Medical School in 1980s Shared Wed What is Pfizer efficacy for months 2, 3, 4, 5, 6? Efficacy for new data is 90.0%, maybe lower than original 94.8% (89.8-97.6%). Does it stay stable or drop? ... Read More »Loading… Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline A... Business Wire 61 upvotes4 comments Mitchell Tsai, Virus researcher at Harvard Medical School in 1980s Shared Apr 6 Dr. McLellan locks the spike protein into a tulip-like prefusion shape by changing 2 amino acids into prolines. This modified spike (2P) is used by Pfizer, Moderna, and J&J... Read More »Loading… Researchers Are Hatching a Low-Cost Coronavirus Vaccine New York Times 55 upvotes10 comments Read more in Coronavirus This email was sent by Quora (605 Castro Street, Mountain View, CA 94041). You were sent this email because you are following Coronavirus. If you don't want these updates anymore, you can unfollow Coronavirus or unsubscribehttp://www.quora.com/